REQUEST A DEMO
Total
USD $0.00
Search more companies

Olla-Med OOO (Олла-Мед ООО) (Russia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Olla-Med OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Olla-Med OOO (Олла-Мед ООО) is a company based in Russia, with its head office in Moscow. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on July 28, 2009. 23 (2023) employees currently work for Olla-Med OOO (Олла-Мед ООО). In its most recent financial highlights, the company reported a net sales revenue increase of 33.4% in 2024. During that time, Olla-Med OOO (Олла-Мед ООО)’s total assets grew by 57.91%. In 2024, Olla-Med OOO (Олла-Мед ООО)’s net profit margin decreased by 6.65%.

Headquarters
9-Ya Parkovaya, 8A
Moscow; Moscow; Postal Code: 105554

Contact Details: Purchase the Olla-Med OOO (Олла-Мед ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Olla-Med OOO (Олла-Мед ООО) report to view the information.
Registered Capital:
Purchase the Olla-Med OOO (Олла-Мед ООО) report to view the information.
Financial Auditors:
Purchase the Olla-Med OOO (Олла-Мед ООО) report to view the information.
Incorporation Date:
July 28, 2009
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Olla-Med OOO (Олла-Мед ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
33.4%
Total operating revenue
33.4%
Operating profit (EBIT)
25.05%
Net Profit (Loss) for the Period
16.81%
Total Assets
57.91%
Total Equity
220.29%
Operating Profit Margin (ROS)
-3.44%
Net Profit Margin
-6.65%
Return on Equity (ROE)
-227.95%
Debt/Equity
-108.2%
Quick Ratio
2.03%
Cash Ratio
1.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?